PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFerric oxyhydroxide
Ferric oxyhydroxide
Ferric Oxyhydroxide, Ferrlecit, Infed, Velphoro, Venofer (ferric oxyhydroxide) is a small molecule pharmaceutical. Ferric oxyhydroxide was first approved as Infed on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Velphoro
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ferric oxyhydroxide
Tradename
Company
Number
Date
Products
VELPHOROViforN-205109 RX2013-11-27
1 products, RLD, RS
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
33 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnemiaD000740EFO_0004272D64.9359218
Iron-deficiency anemiaD018798D501138113
Iron deficienciesD000090463E61.11138113
Chronic kidney failureD007676EFO_0003884N18.611417
Renal insufficiencyD051437N191416
HyperphosphatemiaD05455913126
Chronic renal insufficiencyD051436N18134
Kidney diseasesD007674EFO_0003086N08123
Deficiency diseasesD003677EFO_1001067E631112
Heart failureD006333EFO_0003144I5022
Show 5 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C9511
NeoplasmsD009369C8011
Multiple myelomaD009101C90.011
LymphomaD008223C85.911
Precancerous conditionsD01123011
Lymphoproliferative disordersD008232Orphanet_2442D47.911
Plasma cell neoplasmsD05421911
PlasmacytomaD010954C90.311
Inflammatory bowel diseasesD015212EFO_000376711
Intestinal diseasesD007410K63.911
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DialysisD00395611
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFerric oxyhydroxide
INN_
Description
Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). It is used in form of chewable tablets.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID12134-57-5
RxCUI
ChEMBL IDCHEMBL3039566
ChEBI ID
PubChem CID91502
DrugBank
UNII ID87PZU03K0K (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 701 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
9,912 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use